In Vitro Diagnostic Industry in China - Blood Typing Instruments and Reagents X

3.3.2 Future Development of Blood Typing Instruments

Working Party on Clinical Transfusion Management, Chinese Society of Blood Transfusion investigated blood transfusion departments of 2309 hospitals in different provinces and cities throughout the country through “Internet Plus”; proportion of blood transfusion departments taken as an independent administrative unit is 45% at the moment, proportion of blood transfusion departments under management of laboratory department is 32%, proportion of blood transfusion departments taken as a professional group of laboratory department is 23%, utilization ratio of Automatic blood grouping analyzer is only 40%, while utilization ratio of manual/semi-automatic test instruments is still 60%. Accompanied with promotion and application of fully automated test devices, market size of Automatic blood grouping analyzer is expected surpass manual/semi-automatic test instrument in the next 3–5 years. Besides, accompanied with facilitation of the trend towards administrative independence of blood transfusion department of medical institutions and acceleration of domestic replacement, domestic automatic blood grouping analyzers are expected to achieve greater market coverage.

According to National Health and Family Planning Commission’s statistics, the number of Grade III and Grade II hospitals with blood transfusion department is over 2000 and over 7000 respectively. It is foreseeable that Grade II hospitals and township grassroots hospitals still have relatively large automated blood typing demands in the future. In addition, accompanied with promotion of hierarchical medical system, blood typing instruments of small throughput will future penetrate into county markets with low cost and flexible application scenarios, which will become new growth points that drive market share of blood typing instruments. In the future blood typing sector, whole series of reagents and instruments for Blood typing will be provided to offer all-round blood transfusion test solutions for clinical applications, and satisfaction of use requirements of different clinical units will become the trend. Enterprises in the industry shall stay close to users’ requirements; strengthen their technological innovation efforts in integrated automation, stability, intellectualization, safety and other aspects of products; maintain core competence, achieve growth in competition and realize optimization in growth; and jointly facilitate long-term development of blood typing industry.

Last: In Vitro Diagnostic Industry in China - Blood Typing Instruments and Reagents IX